{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T14:04:43Z","timestamp":1648562683205},"reference-count":19,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1157\/13113776","type":"journal-article","created":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T16:31:22Z","timestamp":1210350682000},"page":"773-774","source":"Crossref","is-referenced-by-count":1,"title":["Aspectos terap\u00e9uticos de la osteoporosis"],"prefix":"10.1016","volume":"129","author":[{"given":"Adolfo","family":"D\u00edez P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13113776_bib1","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"6","article-title":"Anatomy and functions of the adult skeleton","author":"Dempster","year":"2006"},{"key":"10.1157\/13113776_bib2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Women\u2019s Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1157\/13113776_bib3","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","article-title":"WHI Investigators. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women\u2019s Health Initiative: a randomized trial","volume":"289","author":"Wassertheil-Smoller","year":"2003","journal-title":"JAMA"},{"key":"10.1157\/13113776_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1157\/13113776_bib5","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","article-title":"Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure","volume":"18","author":"Jiang","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1157\/13113776_bib6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1157\/13113776_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1157\/13113776_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.rdc.2006.07.003","article-title":"Adherence to medications for the treatment of osteoporosis","volume":"32","author":"Silverman","year":"2006","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1157\/13113776_bib9","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1359\/JBMR.050313","article-title":"Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1157\/13113776_bib10","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1157\/13113776_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","article-title":"One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis","volume":"353","author":"Black","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1157\/13113776_bib12","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2003-032066","article-title":"Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34)","volume":"89","author":"Buxton","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13113776_bib13","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/JBMR.050714","article-title":"Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial","volume":"20","author":"Deal","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1157\/13113776_bib14","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1359\/JBMR.050712","article-title":"Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model","volume":"20","author":"Little","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1157\/13113776_bib15","first-page":"1157","article-title":"Response of BMD to 24 monts of teriparatide (rhPTH 1-34) in patients with and without prior antiresorptive treatment: final results from the EUROFORS study","volume":"21","author":"Obermayer-Pietsch","year":"2006","journal-title":"J Bone Min Res"},{"key":"10.1157\/13113776_bib16","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bone.2007.01.010","article-title":"Changes in micro-CT 3D bone parameters reflect effects of a potent cathepsin K inhibitor (SB-553484) on bone resorption and cortical bone formation in ovariectomized mice","volume":"40","author":"Xiang","year":"2007","journal-title":"Bone"},{"key":"10.1157\/13113776_bib17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1157\/13113776_bib18","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/MCB.25.12.4946-4955.2005","article-title":"Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling","volume":"25","author":"Ai","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1157\/13113776_bib19","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1359\/jbmr.060810","article-title":"Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity","volume":"21","author":"Ellies","year":"2006","journal-title":"J Bone Miner Res"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307729913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307729913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T22:54:51Z","timestamp":1546037691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775307729913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":19,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0025775307729913"],"URL":"https:\/\/doi.org\/10.1157\/13113776","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}